Dr. Massimo Cristofanilli, MD joins Datar Cancer Genetics as Strategic Advisor
Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as Strategic Advisor, reinforcing its commitment to advancing early cancer detection and precision treatment.